Silk Road Medical, Inc. Common Stock
SILK
SILK was delisted on the 16th of September, 2024.
159 hedge funds and large institutions have $2B invested in Silk Road Medical, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 61 increasing their positions, 48 reducing their positions, and 18 closing their positions.
612% more call options, than puts
Call options by funds: $9.52M | Put options by funds: $1.34M
28% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 18
27% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 48
19% more capital invested
Capital invested by funds: $1.68B → $2B (+$316M)
3% more funds holding
Funds holding: 155 → 159 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$27.3M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$22.2M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$21.3M |
| 4 |
Jennison Associates
New York
|
+$18.6M |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$26.8M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$18.2M |
| 3 |
ZCM
Ziegler Capital Management
Chicago,
Illinois
|
-$7.79M |
| 4 |
DM
Deerfield Management
New York
|
-$7.76M |
| 5 |
PA
Perceptive Advisors
New York
|
-$7.04M |
SILK Hedge Fund Activity: Q3 2021 in Review
159 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Silk Road Medical, Inc. Common Stock (SILK) for Q3 2021, worth a combined $2B — up 19% from $1.68B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new SILK positions and 18 closed out — a net gain of 5 holders — while 61 added to existing stakes and 48 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $27.3M. The largest seller was Bellevue Group, cutting an estimated $26.8M.
- 159 institutional investors held Silk Road Medical, Inc. Common Stock (SILK) as of Q3 2021, up from 155 in Q2 2021.
- Funds reported $2B of Silk Road Medical, Inc. Common Stock stock for Q3 2021, up 19% quarter-over-quarter.
- 23 funds opened new Silk Road Medical, Inc. Common Stock positions in Q3 2021 and 18 closed out, a net change of +5 holders.
- The largest Silk Road Medical, Inc. Common Stock buyer in Q3 2021 was AllianceBernstein, an estimated $27.3M added.
- The largest Silk Road Medical, Inc. Common Stock seller in Q3 2021 was Bellevue Group, an estimated $26.8M sold.
Based on aggregated 13F filings for Q3 2021.